Amplio Pharma is a pharmaceutical company that develops proprietary drug products that amplify the efficacy of pharmaceutical treatments.
Amplio Pharma has raised $398K in total funding. The most recent round was Seed. The last funding was announced in April 2025.
Amplio Pharma's investors include Innovatiefonds Noord-Holland.
Amplio Pharma is headquartered in Lund, Sweden.
Amplio Pharma is a pharmaceutical company that develops proprietary drug products that amplify the efficacy of pharmaceutical treatments.
Amplio Pharma is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Amplio Pharma — Funding & Investors." VCBacked, April 24, 2025, https://www.vcbacked.co/company/amplio-pharma. Accessed October 29, 2026.
VCBacked. (2025). Amplio Pharma — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/amplio-pharma
{{cite web |title=Amplio Pharma — Funding & Investors |url=https://www.vcbacked.co/company/amplio-pharma |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated